Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Women With HER2/Neu-Negative Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01022138

Recruitment Status : Unknown

Verified May 2017 by Amy Weise, Barbara Ann Karmanos Cancer Institute.
Recruitment status was: Active, not recruiting

First Posted : December 1, 2009

Last Update Posted : May 22, 2017

Sponsor:

Collaborator:

National Cancer Institute (NCI)

Information provided by (Responsible Party):

Amy Weise, Barbara Ann Karmanos Cancer Institute

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	January 2018
Estimated Study Completion Date :	January 2018

To Top